151 related articles for article (PubMed ID: 1333674)
21. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep.
Bruschke CJ; van Oirschot JT; van Rijn PA
Vaccine; 1999 Apr; 17(15-16):1983-91. PubMed ID: 10217598
[TBL] [Abstract][Full Text] [Related]
22. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
[TBL] [Abstract][Full Text] [Related]
23. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses.
Elahi SM; Shen SH; Talbot BG; Massie B; Harpin S; Elazhary Y
FEMS Microbiol Lett; 1999 Aug; 177(1):159-66. PubMed ID: 10436933
[TBL] [Abstract][Full Text] [Related]
25. A case report: evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine.
Van Campen H; Vorpahl P; Huzurbazar S; Edwards J; Cavender J
J Vet Diagn Invest; 2000 May; 12(3):263-5. PubMed ID: 10826842
[No Abstract] [Full Text] [Related]
26. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
[TBL] [Abstract][Full Text] [Related]
27. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2).
Harpin S; Talbot B; Mbikay M; Elazhary Y
FEMS Microbiol Lett; 1997 Jan; 146(2):229-34. PubMed ID: 9011043
[TBL] [Abstract][Full Text] [Related]
28. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
29. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle.
Loy JD; Gander J; Mogler M; Vander Veen R; Ridpath J; Harris DH; Kamrud K
Virol J; 2013 Jan; 10():35. PubMed ID: 23356714
[TBL] [Abstract][Full Text] [Related]
31. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
32. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.
Rosas CT; König P; Beer M; Dubovi EJ; Tischer BK; Osterrieder N
J Gen Virol; 2007 Mar; 88(Pt 3):748-757. PubMed ID: 17325347
[TBL] [Abstract][Full Text] [Related]
34. Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice.
Grigera PR; Marzocca MP; Capozzo AV; Buonocore L; Donis RO; Rose JK
Virus Res; 2000 Aug; 69(1):3-15. PubMed ID: 10989181
[TBL] [Abstract][Full Text] [Related]
35. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela
Platt R; Kesl L; Guidarini C; Wang C; Roth JA
Vet Immunol Immunopathol; 2017 May; 187():20-27. PubMed ID: 28494925
[TBL] [Abstract][Full Text] [Related]
36. Bovine herpes virus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate.
Kweon CH; Kang SW; Choi EJ; Kang YB
J Vet Med Sci; 1999 Apr; 61(4):395-401. PubMed ID: 10342291
[TBL] [Abstract][Full Text] [Related]
37. Bovine viral diarrhea virus-infected MDBK monolayer as antigen in enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies in bovine sera.
Justewicz DM; Magar R; Marsolais G; Lecomte J
Vet Immunol Immunopathol; 1987 Apr; 14(4):377-84. PubMed ID: 3037768
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
[TBL] [Abstract][Full Text] [Related]
39. Bovine viral diarrhoea virus serology: antibody response after vaccination.
Allock J
Vet Rec; 2001 Feb; 148(7):220. PubMed ID: 11266009
[No Abstract] [Full Text] [Related]
40. Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: assessment of potential to differentiate infected and vaccinated animals.
Raue R; Harmeyer SS; Nanjiani IA
Vet J; 2011 Mar; 187(3):330-4. PubMed ID: 20074985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
